Skip to search formSkip to main contentSkip to account menu

S 12363

Known as: S-12363, Vincaleukoblastine, O4-deacetyl-3-de(methoxycarbonyl)-3-(((1-(diethoxyphosphinyl)-2-methylpropyl)amino)carbonyl)-, (3(S))-, sulfate (salt) 
National Institutes of Health

Related topics

Related topics

4 relations
S 12362

Broader (2)

Vinca Alkaloidsvinfosiltine

Narrower (1)

vinxaltine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Relationship between the cellular accumulation and the cytotoxicity of S12363, a new vinca alkaloid derivative
SummaryS 12363, a new vinca alkaloid derivative, was considerably more cytotoxic to murine L1210 cells and five human tumor cell… 
1993
1993
Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft.
We have established a model of human renal cell carcinoma, Kgg2, transplanted into athymic nude mice which expressed P… 
1991
1991
Characterization of the pharmacological antitumor effects of S 12363, a new vinca alkaloid.
S 12363 is a new highly potent vinca alkaloid derivative characterized by the grafting of an a-aminophosphonate, bioisoster of… 
1990
1990
Pharmacological properties of a new alpha-aminophosphonic acid derivative of vinblastine.
S 12363 is a new vinca alkaloid derivative obtained by grafting an optically active alpha-aminophosphonate at the C23 position of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)